Research

Hormonal

Inhibition of HIF1α signaling allows regenerating skeletal muscle myofibers to bypass a neonatal maturation checkpoint, thereby accelerating muscle repair and growth following injury.

This research identifies a biological 'brake' on muscle repair: if HIF1α signaling stays high after an injury, the muscle gets stuck in an immature, small state. Pharmacologically lowering HIF1α (e.g., with PX-478 in mice) or genetically removing it allows the muscle to mature faster and grow larger. For humans, this suggests that strategies to modulate hypoxia signaling or mitochondrial fusion (Mfn2) might accelerate recovery from severe muscle trauma, though no such therapy is currently available for general use.

GoodSupportsHIGH confidence
Correspondingly, inhibition of HIF1α allowed myofibers to bypass the checkpoint, thereby accelerating the repair process.
Xun Wang et al. · Journal of Clinical Investigation · 2022

Why this rating

Strong evidence from multiple animal models (knockouts, pharmacological inhibition, genetic stabilization) and human patient correlation, though not a human clinical trial.

Source

A mitofusin 2/HIF1α axis sets a maturation checkpoint in regenerating skeletal muscle

Xun Wang et al. · Journal of Clinical Investigation · 2022

DOI 10.1172/jci161638

mechanism_onlyCited 18×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →